EOM 1352: Fri 7 June 2024, 11:36

Current Edition

Discovery Park: Wed 13 November 2024, 10:35
ramusmedical
Europe

Researchers Develop Diagnostic for Rare Cancer-Generated Glycoproteins

Engineered chemical trap detects rare glycoproteins emitted as cancer first develops. Researchers at the Georgia Institute of Technology have designed a boronic acid ...
Continue Reading →
Europe

US researchers develop tool to improve diagnostic accuracy

The tool has been used to analyse protein variation in diabetes, cancer, cardiovascular disease, neuro and retinal degeneration. A research team at the University at...
Continue Reading →
Europe

Proteomics launches diagnostic test leader ‘PromarkerD’

Proteomics International is engaged with potential partners to bring PromarkerD to market in mainland USA, Mexico, Japan, Australia, China and Europe. MedTech pione...
Continue Reading →
news

Proteomics and Dimerix partner to improve the treatment of kidney disease

Australia-based Proteomics International (PI) has developed PromarkerD, a predictive and diagnostic test for diabetic kidney disease that measures a protein biomarker...
Continue Reading →
Catalyst: 12th January 2026
Quotient